Investing Profile

Matias Serebrinsky(679)

VCFounderOperator

Mental health and psychedelic therapeutics investor. Cofounder and GP at PsyMed Ventures.

psymed.venturesSan Francisco Bay Area

Your Intro Paths to Matias Serebrinsky

Signal uses Gmail to reveal intro paths. Email content is never read.

Matias Serebrinsky's investing connections

26 Investors

Connected to Satya Patel (Homebrew), Aileen Lee (Cowboy Ventures), Morgan Beller (NFX), and 23 other investors on Signal.

Find Matias Serebrinsky on

Current Investing Position

PsyMed Ventures General Partner

Investment Range

$100K - $2.5M

Sweet Spot

$500K

Investments On Record

Matias Serebrinsky is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Seed)BioTech (Series A)Pharmaceuticals (Series A)Health IT (Series A)Investors who were founders Investors who invested in female founders Investors who invested in diverse founders San Francisco Bay Area DeepTech (Series A)DeepTech (Seed)Pharmaceuticals (Pre-seed)DeepTech (Pre-seed)Health IT (Pre-seed)Digital Health (Pre-seed)BioTech (Pre-seed)Health IT (Seed)Digital Health (Series A)Digital Health (Seed)

Matias Serebrinsky's Investments On Record (7)

Company	StageDateRound Size	Total Raised
Delix Therapeutics	Series ASep 2021$70M	$70M
Co-investors: Vasudev Bailey (Artis Ventures (AV)), Ken Belotsky (Negev Capital)
Mindstate	Seed+Sep 2021$250K	$250K
Journey Clinical	SeedAug 2021$250K Pre-seedFeb 2021$150K	$12M
Co-investors: Daniel Love (Beckley Waves), Mack Luby (Mystic Ventures), Edvard Engesæth
Beckley Psytech	Series BJun 2021$1	$80M £58M
Co-investors: Eric Brook (B Capital Group), Kunal Sethi (Prithvi Ventures), Stephen Hays (What If Ventures), Amy Kruse (Satori Capital), Ken Belotsky (Negev Capital)
ATAI Life Sciences	Series DFeb 2021$3.6M Series COct 2020$130M	$220M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds), Ken Belotsky (Negev Capital), Stephen Hays (What If Ventures), Maryanna Saenko (Future Ventures), Akshay Sriprasad
Maya Health	SeedOct 2020$100K	$100K
Co-investors: Mack Luby (Mystic Ventures)
TRIPP	Series ASep 2017$4M	$15M
Co-investors: Malte Barth (BITKRAFT Ventures), Paul Palmieri (Grit Capital Partners), Vijay Chattha (VSC Ventures), Ted Moskovitz

most interested in

Investing in psychedelic medicine and tech that elevates health & wellness. Focus areas: -Psychedelics & New Compounds -Neurotech & BCI -Precision Psychiatry -Digital Therapeutics

Matias Serebrinsky's Experience

Head of Inception (startup ecosystem) NVIDIA2016 - 2021

Cofounder CookUnity2014 - 2016

Investors who invest with Matias Serebrinsky